Ji Hyun Kim

Dr. Ji Hyun Kim

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2021 in Diagnostics
Verified
Journal Article
Open access
PDF file
JKJi Hyun Kim
Ji Hyun Kim
SNSeung-Joo Nam
Seung-Joo Nam
Wireless capsule endoscopy was first developed to observe the small intestine. A small capsule can be swallowed and images of gastrointestinal tract are taken with natural movement of peristalsis. Application of capsule endoscopy for observing the stomach has also received much attention as a useful alternative to esophagogastroduodenoscopy, but anatomical characteristics of the stomach have demanded technical obstacles that need to be tackled: clear visualization and active movements that could be controlled. Different methods of controlling the capsule within stomach have been studied and magnetic manipulation is the only system that is currently used in clinical settings. Magnets within the capsule can be controlled with a hand-held magnet paddle, robotic arm, and electromagnetic coil system. Studies on healthy volunteers and patients with upper gastrointestinal symptoms have shown that it is a safe and effective alternative method of observing the stomach. This work reviews different magnetic locomotion systems that have been used for observation of the stomach as an emerging new application of wireless capsule endoscopy.

22 February 2024 in Gut and Liver
Verified
Journal Article
Open access
PDF file
JCJae Myung Cha
Jae Myung Cha
MKMyoungsuk Kim
Myoungsuk Kim
HJHyeong Ho Jo
Hyeong Ho Jo
WSWon-Woo Seo
Won-Woo Seo
SRSang Youl Rhee
Sang Youl Rhee
JPJunseok Park
Junseok Park
Jae Myung Cha, Myoungsuk Kim, Hyeong Ho Jo, Won-Woo Seo, Sang Youl Rhee, Ji Hyun Kim, Gwang Ha Kim, Junseok Park. Gut and Liver 2024;18:814-23. https://doi.org/10.5009/gnl230406

21 March 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
HCHyunseok Cho
Hyunseok Cho
JLJung Ho Lee
Jung Ho Lee
SPSung Chul Park
Sung Chul Park
SNSeung-Joo Nam
Seung-Joo Nam
HYHee-Jeong Youk
Hee-Jeong Youk
SLSang Hoon Lee
Sang Hoon Lee
Background/Aim: Bacterial and viral gastroenteritis present with overlapping symptoms, including vomiting, diarrhea, and abdominal pain. Stool tests have been used to differentiate between them; however, stool cultures are time-consuming and stool polymerase chain reaction (PCR) tests are expensive. The role of the clinical value of procalcitonin (PCT) and C-reactive protein (CRP) as diagnostic markers of bacterial gastroenteritis remains to be investigated. This study evaluated the diagnostic value of PCT for the early diagnosis of bacterial gastroenteritis. Methods: The medical records of patients diagnosed with gastroenteritis by the emergency department with positive stool PCR results confirming the diagnosis between 1 January 2020 and 31 July 2024 were retrospectively reviewed. Demographic characteristics and laboratory findings, including PCT and CRP levels, were analyzed. The area under the curve (AUC) for the diagnosis of bacterial gastroenteritis was assessed to determine the diagnostic potential of PCT and CRP. Results: Among the 1882 cases identified, 1435 met the inclusion criteria. CRP exhibited a sensitivity of 79.0% and specificity of 78.6% (AUC: 0.848, 95% CI: 0.815–0.881) in diagnosing bacterial gastroenteritis. In comparison, PCT showed lower sensitivity (60.3%) and specificity (62.6%) (AUC: 0.660, 95% CI: 0.614–0.706). However, in patients aged >17 years with fever (≥38 °C), PCT demonstrated an improved AUC of 0.767 (95% CI: 0.603–0.932; p = 0.019). Conclusions: CRP demonstrated moderate sensitivity in predicting bacterial gastroenteritis; however, its false-negative rate suggests limitations in clinical decision-making. While PCT may assist clinicians in identifying bacterial gastroenteritis in febrile adult patients, its diagnostic accuracy remains suboptimal, necessitating further validation through larger studies.

1 October 2020 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
PDF file
JKJi Hyun Kim
Ji Hyun Kim
SKSeong Hee Kang
Seong Hee Kang
MLMinjong Lee
Minjong Lee
HCHoon Sung Choi
Hoon Sung Choi
BJBaek Gyu Jun
Baek Gyu Jun
DKDong Joon Kim
Dong Joon Kim

31 October 2022 in Annals of Rehabilitation Medicine
Verified
Journal Article
Open access
PDF file
JPJintae Park
Jintae Park
SBSora Baek
Sora Baek
GKGowun Kim
Gowun Kim
SNSeung-Joo Nam
Seung-Joo Nam
JKJi Hyun Kim
Ji Hyun Kim
Objective To investigate esophageal motility disorders in patients with esophageal residual barium on chest x-rays after videofluoroscopic swallowing studies (VFSS) through high-resolution esophageal manometry (HREM).Methods We reviewed the records of 432 patients who underwent VFSS from September 2019 to May 2021, and 85 patients (19.7%) with large residual barium (diameter ≥1 cm) were included. As a result of HREM, motility disorders were classified as major or minor motility disorders according. Esophagogastroduodenoscopy and chest computed tomography results available were also reviewed.Results Among 85 patients with large residual barium in the esophagus, 16 patients (18.8%) underwent HREM. Abnormal esophageal motilities were identified in 68.8% patient: three patients (18.8%) had major motility disorders—achalasia (n=1), esophagogastric junction (EGJ) outflow obstruction (n=2)—and eight patients (50%) had minor motility disorders—ineffective esophageal motility (n=7), fragmented peristalsis (n=1). In those with normal esophageal motility, three patients of esophageal structure disorders (18.8%)—esophageal cancer (n=1), cardiogenic dysphagia (n=1), slight narrowing without obstruction of EGJ (n=1)—and two patients (12.5%) with chronic atrophic gastritis (n=2) were confirmed.Conclusion Esophageal motility disorders were identified in 68.8% of 16 patients with large esophageal residual barium with three patients in the major and eight patients in the minor categories. Residual barium in the esophagus was not rare and can be a sign of significant esophageal motility disorders.

14 August 2020 in European Journal of Gastroenterology & Hepatology
Verified
Journal Article
Closed access
JKJi Hyun Kim
Ji Hyun Kim
SKSeong Hee Kang
Seong Hee Kang
MLMinjong Lee
Minjong Lee
HCHoon Sung Choi
Hoon Sung Choi
BJBaek Gyu Jun
Baek Gyu Jun
Dong Joon KimDong Joon Kim
Dong Joon Kim
Background and aims: Current guidelines for chronic hepatitis B (CHB) patients are to undergo surveillance for hepatocellular carcinoma (HCC) with 6-month ultrasonography. We aimed to compare detection rates of very-early-stage HCC in two groups: group A, undergoing 6-month ultrasonography versus group B, undergoing 6-month ultrasonography alternating with dynamic computed tomography (CT). Methods: This retrospective study assessed 2151 CHB patients under entecavir/tenofovir therapy from 2007 to 2016. Detection rates of very-early-stage HCC were compared between groups A/B at intermediate/high risk based on platelets, age, gender-hepatitis B scores. The primary endpoint was the proportion of patients in each group with very-early-stage HCC. Cox proportional hazards model was used to assess the effect of surveillance modalities to detect very-early-stage HCC. Results: Five-year cumulative HCC incidence rates in group A were 15.0% not significantly different from 18.2% in group B at high risk (P = 0.17). Detection rates of very-early-stage HCC were significantly higher in group B than in group A (P < 0.001), and surveillance using CT alternating with ultrasonography was significantly associated with detection of very-early-stage HCC (hazard ratio 3.89, P < 0.001). Among intermediate-risk patients, difference between detection rates of very-early-stage HCC in groups A and B was not significant (P = 0.30), and surveillance using CT alternating with ultrasonography was not significantly associated with detection of very-early-stage HCC (hazard ratio 1.61, P = 0.23). Conclusion: In high-risk CHB patients, surveillance using CT alternating with ultrasonography led to higher detection rates of very-early-stage HCC compared to surveillance using ultrasonography.